发明名称 CLAY PIPE CANCER THERAPY
摘要 <p>FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely to oncology, and can be used within integrated treatment of locally advanced clay pipe cancer. That is ensured by blood sampling in the amount 200-250 ml from the median cubital vein, centrifugation and plasma separation in the amount 10 ml in 9 syringes of 20 ml. Plasma containers are placed in a freezing chamber, and the rest cell suspension is added with 150 ml of physiologic saline and reinfused intravenously drop-by-drop. On the following day, the lingual artery is catheterised to introduce a mixture incubated at temperature 37 C for 30 minutes and containing 10 ml of autoplasma and 30 mg of methotrexate in one syringe and 500 mg of 5-fluorouracil and 10 ml of autoplasma in the second syringe. Such mixture is introduced daily during 4 days. 3 weeks later, a surgical removal the tumour follows with a bed of the removed tumour being injected all around during the operation with the mixture of 30 mg methotrexate and 10 ml of autoplasma incubated similarly that is followed with operative wound closure. ^ EFFECT: method allows higher clinical effectiveness in the case patients that is ensured by chemopreparations depot in a tumour lesion. ^ 1 ex</p>
申请公布号 RU2403917(C1) 申请公布日期 2010.11.20
申请号 RU20090121806 申请日期 2009.06.08
申请人 FEDERAL'NOE GOSUDARSTVENNOE UCHREZHDENIE ROSTOVSKIJ NAUCHNO-ISSLEDOVATEL'SKIJ ONKOLOGICHESKIJ INSTITUT ROSMEDTEKHNOLOGIJ;SVETITSKIJ PAVEL VIKTOROVICH;GANIEV ABDUAVAZ ABDULAKHATOVICH;KALIJ VASILIJ VASIL'EVICH;VOLKOVA VIKTORIJA L'VOVNA 发明人 SVETITSKIJ PAVEL VIKTOROVICH;GANIEV ABDUAVAZ ABDULAKHATOVICH;KALIJ VASILIJ VASIL'EVICH;VOLKOVA VIKTORIJA L'VOVNA
分类号 A61B17/00;A61K31/196;A61K31/513;A61M1/38;A61P35/00 主分类号 A61B17/00
代理机构 代理人
主权项
地址